Greatbatch, Inc. Requests CE Mark For Spinal Cord Stim

Published: Jan 21, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Greatbatch files for European CE Mark for its spinal cord stimulation system, hoping to land marketing approval the treatment of chronic pain of the trunk and limbs. Greatbatch (NYSE:GB) filed a CE Mark application for its spinal cord stimulation system with German notified body TÜV SÜD America. The spinal cord stimulation system comes from Greatbatch's subsidiary, QiG Group.

Help employers find you! Check out all the jobs and post your resume.

Back to news